516 related articles for article (PubMed ID: 25711197)
1. Lynch Syndrome: A Primer for Urologists and Panel Recommendations.
Mork M; Hubosky SG; Rouprêt M; Margulis V; Raman J; Lotan Y; O'Brien T; You N; Shariat SF; Matin SF
J Urol; 2015 Jul; 194(1):21-9. PubMed ID: 25711197
[TBL] [Abstract][Full Text] [Related]
2. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
Rouprêt M; Yates DR; Comperat E; Cussenot O
Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
[TBL] [Abstract][Full Text] [Related]
3. Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma.
Metcalfe MJ; Petros FG; Rao P; Mork ME; Xiao L; Broaddus RR; Matin SF
J Urol; 2018 Jan; 199(1):60-65. PubMed ID: 28797715
[TBL] [Abstract][Full Text] [Related]
4. Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors.
Lonati C; Necchi A; Gómez Rivas J; Afferi L; Laukhtina E; Martini A; Ventimiglia E; Colombo R; Gandaglia G; Salonia A; Briganti A; Montorsi F; Mattei A; Simeone C; Carlo MI; Shariat SF; Spiess PE; Moschini M;
Eur Urol Oncol; 2022 Feb; 5(1):30-41. PubMed ID: 34896051
[TBL] [Abstract][Full Text] [Related]
5. Lynch syndrome in upper tract urothelial carcinoma: significance, screening, and surveillance.
Pradere B; Lotan Y; Roupret M
Curr Opin Urol; 2017 Jan; 27(1):48-55. PubMed ID: 27533503
[TBL] [Abstract][Full Text] [Related]
6. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
7. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.
Audenet F; Colin P; Yates DR; Ouzzane A; Pignot G; Long JA; Soulie M; Phé V; Bensadoun H; Guy L; Ruffion A; Valeri A; Cormier L; Droupy S; de La Taille A; Saint F; Faïs PO; Houlgatte A; Cussenot O; Rouprêt M;
BJU Int; 2012 Dec; 110(11 Pt B):E583-9. PubMed ID: 22703159
[TBL] [Abstract][Full Text] [Related]
8. Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome).
Hubosky SG; Boman BM; Charles S; Bibbo M; Bagley DH
BJU Int; 2013 Oct; 112(6):813-9. PubMed ID: 23452166
[TBL] [Abstract][Full Text] [Related]
9. Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis.
Blaszyk H; Wang L; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Hartmann A
Mod Pathol; 2002 Aug; 15(8):790-7. PubMed ID: 12181263
[TBL] [Abstract][Full Text] [Related]
10. Genetic testing in gastroenterology: Lynch syndrome.
Grover S; Syngal S
Best Pract Res Clin Gastroenterol; 2009; 23(2):185-96. PubMed ID: 19414145
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review.
Lindor NM; Petersen GM; Hadley DW; Kinney AY; Miesfeldt S; Lu KH; Lynch P; Burke W; Press N
JAMA; 2006 Sep; 296(12):1507-17. PubMed ID: 17003399
[TBL] [Abstract][Full Text] [Related]
12. Lynch syndrome and MYH-associated polyposis: review and testing strategy.
Goodenberger M; Lindor NM
J Clin Gastroenterol; 2011 Jul; 45(6):488-500. PubMed ID: 21325953
[TBL] [Abstract][Full Text] [Related]
13. Lynch syndrome in urological practice: diagnosis, therapeutic strategies, and screening for upper tract urothelial carcinoma.
Lonati C; Moschini M; Simeone C; Spiess PE; Necchi A
Curr Opin Urol; 2022 Jan; 32(1):40-47. PubMed ID: 34608026
[TBL] [Abstract][Full Text] [Related]
14. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
Burger M
Eur Urol; 2008 Dec; 54(6):1236. PubMed ID: 18715704
[No Abstract] [Full Text] [Related]
15. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
Mongiat-Artus P
Eur Urol; 2008 Dec; 54(6):1235-6. PubMed ID: 18715693
[No Abstract] [Full Text] [Related]
16. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
Schofield L; Goldblatt J; Iacopetta B
Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
[TBL] [Abstract][Full Text] [Related]
17. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
[TBL] [Abstract][Full Text] [Related]
18. Population-based molecular screening for Lynch syndrome: implications for personalized medicine.
Ward RL; Hicks S; Hawkins NJ
J Clin Oncol; 2013 Jul; 31(20):2554-62. PubMed ID: 23733757
[TBL] [Abstract][Full Text] [Related]
19. Systematic Review: An Update on the Spectrum of Urological Malignancies in Lynch Syndrome.
Huang D; Matin SF; Lawrentschuk N; Roupret M
Bladder Cancer; 2018 Jul; 4(3):261-268. PubMed ID: 30112437
[TBL] [Abstract][Full Text] [Related]
20. Molecular subtype classification of urothelial carcinoma in Lynch syndrome.
Therkildsen C; Eriksson P; Höglund M; Jönsson M; Sjödahl G; Nilbert M; Liedberg F
Mol Oncol; 2018 Aug; 12(8):1286-1295. PubMed ID: 29791078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
